05.01.2018 - Specialty pharmaceuticals manufacturer Mallinckrodt has agreed to buy biopharmaceuticals producer Sucampo, including its commercial and development assets. The transaction is...
Advertising Opportunities Print, Digital & Content Solutions
LinkedIn | X (Twitter)